NO883994D0 - Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer.

Info

Publication number
NO883994D0
NO883994D0 NO883994A NO883994A NO883994D0 NO 883994 D0 NO883994 D0 NO 883994D0 NO 883994 A NO883994 A NO 883994A NO 883994 A NO883994 A NO 883994A NO 883994 D0 NO883994 D0 NO 883994D0
Authority
NO
Norway
Prior art keywords
pyrimidinylamines
procedure
preparation
radical
therapeutic active
Prior art date
Application number
NO883994A
Other languages
English (en)
Other versions
NO883994L (no
Inventor
Philippe Manoury
Alfred Saarmets
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO883994D0 publication Critical patent/NO883994D0/no
Publication of NO883994L publication Critical patent/NO883994L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
NO88883994A 1987-09-09 1988-09-08 Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer. NO883994L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712502A FR2620121B1 (fr) 1987-09-09 1987-09-09 ((pyrimidinyl-2)-aminoalkyl)-1 piperidines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO883994D0 true NO883994D0 (no) 1988-09-08
NO883994L NO883994L (no) 1989-03-10

Family

ID=9354744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883994A NO883994L (no) 1987-09-09 1988-09-08 Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer.

Country Status (18)

Country Link
US (2) US4891376A (no)
EP (1) EP0307303B1 (no)
JP (1) JPH01104069A (no)
KR (1) KR890005086A (no)
AT (1) ATE70062T1 (no)
AU (1) AU603004B2 (no)
DE (1) DE3866646D1 (no)
DK (1) DK499088A (no)
ES (1) ES2040879T3 (no)
FI (1) FI884132A (no)
FR (1) FR2620121B1 (no)
GR (1) GR3003481T3 (no)
HU (1) HU199141B (no)
IL (1) IL87609A (no)
NO (1) NO883994L (no)
NZ (1) NZ226089A (no)
PT (1) PT88460B (no)
ZA (1) ZA886698B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618436B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5231104A (en) * 1988-07-08 1993-07-27 Pfizer Inc. 1-arylethyl-3-substituted piperidines
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
KR100351012B1 (ko) * 1994-04-20 2002-12-26 아지노모토 가부시키가이샤 피페리딘유도체및이를함유하는항혈소판제
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
JP2914324B2 (ja) * 1995-10-23 1999-06-28 味の素株式会社 ピペリジン誘導体の結晶並びにその製造中間体及び製造方法
US5869497A (en) * 1996-03-15 1999-02-09 Eli Lilly And Company Method of treating or ameliorating the symptoms of common cold or allergic rhinitis
US7180322B1 (en) 2002-04-16 2007-02-20 Transmeta Corporation Closed loop feedback control of integrated circuits
US7941675B2 (en) * 2002-12-31 2011-05-10 Burr James B Adaptive power control
US7953990B2 (en) * 2002-12-31 2011-05-31 Stewart Thomas E Adaptive power control based on post package characterization of integrated circuits
US7949864B1 (en) * 2002-12-31 2011-05-24 Vjekoslav Svilan Balanced adaptive body bias control
US7228242B2 (en) 2002-12-31 2007-06-05 Transmeta Corporation Adaptive power control based on pre package characterization of integrated circuits
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US7129771B1 (en) 2003-12-23 2006-10-31 Transmeta Corporation Servo loop for well bias voltage source
US7012461B1 (en) 2003-12-23 2006-03-14 Transmeta Corporation Stabilization component for a substrate potential regulation circuit
US7692477B1 (en) 2003-12-23 2010-04-06 Tien-Min Chen Precise control component for a substrate potential regulation circuit
US7649402B1 (en) 2003-12-23 2010-01-19 Tien-Min Chen Feedback-controlled body-bias voltage source
US7774625B1 (en) 2004-06-22 2010-08-10 Eric Chien-Li Sheng Adaptive voltage control by accessing information stored within and specific to a microprocessor
KR101379783B1 (ko) 2008-01-30 2014-03-31 니폰 조키 세야쿠 가부시키가이샤 피페리딘 유도체
JP5083989B2 (ja) * 2008-11-20 2012-11-28 日本臓器製薬株式会社 ピペリジン誘導体を含有する医薬
CN103619839B (zh) * 2011-06-28 2016-06-01 福建省闽东力捷迅药业有限公司 抗-变态反应的苯并环庚并噻吩衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives

Also Published As

Publication number Publication date
PT88460B (pt) 1992-11-30
FI884132A0 (fi) 1988-09-08
AU603004B2 (en) 1990-11-01
IL87609A (en) 1992-09-06
FI884132A (fi) 1989-03-10
FR2620121B1 (fr) 1990-01-05
DE3866646D1 (de) 1992-01-16
DK499088D0 (da) 1988-09-08
JPH01104069A (ja) 1989-04-21
HUT47927A (en) 1989-04-28
PT88460A (pt) 1988-10-01
FR2620121A1 (fr) 1989-03-10
DK499088A (da) 1989-04-03
ES2040879T3 (es) 1993-11-01
KR890005086A (ko) 1989-05-11
AU2201088A (en) 1989-03-23
EP0307303A1 (fr) 1989-03-15
NO883994L (no) 1989-03-10
HU199141B (en) 1990-01-29
US4929621A (en) 1990-05-29
EP0307303B1 (fr) 1991-12-04
IL87609A0 (en) 1989-01-31
ATE70062T1 (de) 1991-12-15
NZ226089A (en) 1990-06-26
ZA886698B (en) 1989-04-26
GR3003481T3 (en) 1993-02-17
US4891376A (en) 1990-01-02

Similar Documents

Publication Publication Date Title
NO883994L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer.
DK359387D0 (da) Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling
DK316279A (da) Fluren- og fluorantenderivater deres fremstilling og anvendelse i terapeutiske praeparater samt mellemprodukter
FR2618436B1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
ZA922625B (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
SE7605899L (sv) Forfarande for framstellning av tienopyridinderivat
FI890690A (fi) Nya basiskt substituerade 5-halogen-tienoisotiazol-3(2h)-on-1,1-dioxider, foerfarande foer deras framstaellning och dessa foereningar innehaollande farmaceutiska preparat.
ES2037783T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas.
ES8504193A1 (es) Un procedimiento de preparacion de hexahidro-indolo-naftiridinas